1. Home
  2. BTO vs CTKB Comparison

BTO vs CTKB Comparison

Compare BTO & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BTO
  • CTKB
  • Stock Information
  • Founded
  • BTO 1994
  • CTKB 1990
  • Country
  • BTO United States
  • CTKB United States
  • Employees
  • BTO N/A
  • CTKB N/A
  • Industry
  • BTO Investment Managers
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • BTO Finance
  • CTKB Health Care
  • Exchange
  • BTO Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • BTO 703.7M
  • CTKB 718.8M
  • IPO Year
  • BTO N/A
  • CTKB 2021
  • Fundamental
  • Price
  • BTO $36.18
  • CTKB $5.12
  • Analyst Decision
  • BTO
  • CTKB Strong Buy
  • Analyst Count
  • BTO 0
  • CTKB 2
  • Target Price
  • BTO N/A
  • CTKB $9.25
  • AVG Volume (30 Days)
  • BTO 54.2K
  • CTKB 760.6K
  • Earning Date
  • BTO 01-01-0001
  • CTKB 02-27-2025
  • Dividend Yield
  • BTO 9.13%
  • CTKB N/A
  • EPS Growth
  • BTO N/A
  • CTKB N/A
  • EPS
  • BTO N/A
  • CTKB N/A
  • Revenue
  • BTO N/A
  • CTKB $201,210,000.00
  • Revenue This Year
  • BTO N/A
  • CTKB $7.26
  • Revenue Next Year
  • BTO N/A
  • CTKB $8.20
  • P/E Ratio
  • BTO N/A
  • CTKB N/A
  • Revenue Growth
  • BTO N/A
  • CTKB 9.88
  • 52 Week Low
  • BTO $22.95
  • CTKB $4.66
  • 52 Week High
  • BTO $32.81
  • CTKB $9.33
  • Technical
  • Relative Strength Index (RSI)
  • BTO 39.89
  • CTKB 37.48
  • Support Level
  • BTO $35.73
  • CTKB $5.18
  • Resistance Level
  • BTO $37.78
  • CTKB $5.48
  • Average True Range (ATR)
  • BTO 0.77
  • CTKB 0.27
  • MACD
  • BTO -0.19
  • CTKB 0.01
  • Stochastic Oscillator
  • BTO 14.50
  • CTKB 27.85

About BTO John Hancock Financial Opportunities Fund

John Hancock Financial Opportunities Fund is the United States based closed-end, diversified management investment company. Its investment objective is to provide a high level of total return consisting of long-term capital appreciation and current income. The portfolio composition of the fund includes common stocks, corporate bonds, preferred securities, investment companies, and short-term investments.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: